These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 22628299)
1. Polyglutamine tracts as modulators of transcriptional activation from yeast to mammals. Atanesyan L; Günther V; Dichtl B; Georgiev O; Schaffner W Biol Chem; 2012 Jan; 393(1-2):63-70. PubMed ID: 22628299 [TBL] [Abstract][Full Text] [Related]
2. Sir2 is induced by oxidative stress in a yeast model of Huntington disease and its activation reduces protein aggregation. Sorolla MA; Nierga C; Rodríguez-Colman MJ; Reverter-Branchat G; Arenas A; Tamarit J; Ros J; Cabiscol E Arch Biochem Biophys; 2011 Jun; 510(1):27-34. PubMed ID: 21513696 [TBL] [Abstract][Full Text] [Related]
3. Modifier pathways in polyglutamine (PolyQ) diseases: from genetic screens to drug targets. Costa MD; Maciel P Cell Mol Life Sci; 2022 May; 79(5):274. PubMed ID: 35503478 [TBL] [Abstract][Full Text] [Related]
4. Monitoring polyglutamine toxicity in yeast. Duennwald ML Methods; 2011 Mar; 53(3):232-7. PubMed ID: 21144902 [TBL] [Abstract][Full Text] [Related]
5. Three classes of mammalian transcription activation domain stimulate transcription in Schizosaccharomyces pombe. Remacle JE; Albrecht G; Brys R; Braus GH; Huylebroeck D EMBO J; 1997 Sep; 16(18):5722-9. PubMed ID: 9312030 [TBL] [Abstract][Full Text] [Related]